Streetbeat News

Stock Prices

VKTX

Viking Therapeutics (NYSE:VKTX) has seen a decrease in short interest, now at 14.82% of its float, down 6.26% from the last report. With 12.92 million shares sold short, it would take about 4.9 days to cover all short positions. This change in short interest could indicate a shift in market sentiment towards VKTX, potentially signaling increased bullishness among investors. Viking's short interest is higher than its peer group average of 11.82%, suggesting more bearish sentiment compared to its peers.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 5:00 pm

BGLC

BioNexus Gene Lab (NYSE:BGLC) has seen a significant increase in short interest, with a 326.67% rise since the last report, representing 0.64% of its float. This increase in short interest, which now stands at 93 thousand shares, suggests a bearish market sentiment towards BGLC. However, compared to its peers' average short interest of 2.32%, BGLC's short interest is relatively low. The article highlights the importance of monitoring short interest as it can indicate market sentiment and potentially influence stock prices.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 5:00 pm

NOV

Piper Sandler has maintained its Neutral rating on NOV (NYSE:NOV) but lowered its price target from $25.00 to $22.00. NOV's shares have fallen 0.75% in the last 24 hours to $17.09. A price target of $22.00 represents a 28.73% increase from the current price. NOV is a global leader in supplying oil and gas drilling equipment, with over 60% of its revenue coming from international markets.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 5:00 pm

MPW

Medical Properties Trust (NYSE:MPW) has received mixed analyst ratings over the past three months, with a recent shift towards a more bearish outlook. The average 12-month price target is now $4.75, a significant decrease from the previous $8.33. Analysts from RBC Capital, Deutsche Bank, Mizuho, and JP Morgan have adjusted their ratings and price targets, reflecting concerns over the company's revenue decline, market capitalization, and financial performance despite its strong net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 5:00 pm

CMI

Evercore ISI Group has maintained its In-Line rating for Cummins (NYSE:CMI) and increased its price target from $231.00 to $244.00. Despite a current trading price of $263.85, which is down 0.99% over the last 24 hours, the new target suggests a potential decline of 7.52%. Cummins is a leading manufacturer of diesel engines and powertrain components, facing competition from heavy-duty truck manufacturers and regulatory challenges.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 5:00 pm

HRL

Hormel Foods (NYSE:HRL) has seen a 6.25% increase in short interest since its last report, with 12.97 million shares sold short, representing 2.38% of its float. It would take about 4.38 days to cover all short positions. This rise in short interest could indicate a more bearish market sentiment towards HRL, although it has less short interest compared to its peers' average of 5.30%.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 5:00 pm

RS

BMO Capital has maintained its Outperform rating for Reliance (NYSE:RS) and increased its price target from $295.00 to $355.00. Despite a slight decrease in share price over the last 24 hours, the new target suggests a potential 9.1% increase.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 5:00 pm

KBR

KBR, Inc. (NYSE:KBR) reported Q4 adjusted earnings per share of 69 cents, matching expectations, but missed quarterly sales estimates with $1.73 billion versus the expected $1.787 billion. Year-over-year, revenue rose 8%, and adjusted EBITDA increased by 20%. The company's backlog increased by 10% to $21.7 billion. KBR raised its quarterly dividend by 11% to $0.15 per share and replenished its share repurchase authorization to $500 million. For FY24, KBR forecasts revenue between $7.4 billion and $7.7 billion, slightly below the $7.73 billion estimate, with adjusted EPS of $3.10-$3.30, against an estimate of $3.26. KBR shares rose 4.33% to $57.69.

Portfolio Pulse from Nabaparna Bhattacharya

February 20, 2024 | 4:56 pm

AXSM

Axsome Therapeutics' stock price declined following the announcement of worse-than-expected Q4 earnings per share (EPS) results.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 4:55 pm

BAC

C

GS

JPM

KRE

MS

NYCB

SFBS

VLY

WFC

XLF

Rising delinquencies in the commercial real estate sector are causing concerns for major banks like JPMorgan Chase, Bank of America, Wells Fargo, Citigroup, Goldman Sachs, and Morgan Stanley, as bad loans begin to exceed loss reserves. The Financial Times reports a significant drop in average reserves against delinquent debt, with a nearly tripled delinquent debt reaching $9.3 billion. The banking sector's scrutiny by regulators increases as delinquent loans tied to commercial properties more than double to $24.3 billion. The Financials SPDR Select Sector Fund and the SPDR S&P 500 Regional Banking ETF saw declines, with New York Community Bancorp, ServisFirst Bancshares, and Valley National Bancorp experiencing notable stock drops.

Portfolio Pulse from Piero Cingari

February 20, 2024 | 4:53 pm